Key result
APOA5 SNP rs662799 linked to ~47% higher metabolic syndrome risk, driven by plasma triglycerides.
Why the study?
Is the APOA5 SNP rs662799 (-1131T>C) polymorphism associated with metabolic syndrome in Chinese populations?
Cohort (n=3,282)
Yes
Is the APOA5 SNP rs662799 (-1131T>C) polymorphism associated with metabolic syndrome in Chinese populations?
Odds Ratio: 1.47
p-value: p=0.00082
The APOA5 -1131T>C polymorphism is associated with metabolic syndrome in Chinese populations, primarily driven by its strong effect on plasma triglycerides.
May inform triglyceride-focused risk assessment in Chinese patients; extends genetic associations but remains hypothesis-generating.
OBJECTIVE: Single nucleotide polymorphisms (SNPs) in the apolipoprotein A5 gene (APOA5) are associated with hypertriglyceridaemia in our population. We studied the associations of SNPs in APOA5 with the metabolic syndrome (MetS) in the Hong Kong and Guangzhou Chinese. METHODS: We genotyped five tagging SNPs in 1330 unrelated subjects from the Hong Kong Cardiovascular Risk Factor Prevalence Study cohort with follow-up after a median interval of 6·4 years; 1952 subjects from the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort were used to replicate the findings. The MetS was defined according to the consensus criteria proposed jointly by several organizations in 2009. RESULTS: The SNP rs662799 (-1131T>C) was associated with the MetS (odds ratio = 1·47, P = 0·00082) and the number of its components present (regression coefficient = 0·204, P = 4·6 × 10(-5) ) after adjusting for age, sex, smoking, drinking and education in Hong Kong subjects at baseline. Similar association of this SNP was found in Hong Kong subjects at follow-up (P = 0·010 and 0·00021, respectively) and in Guangzhou subjects (P = 0·0041 and 0·017, respectively). The association of rs662799 with the number of the MetS components was significant regardless of age, sex, obesity and alcohol drinking, but almost disappeared after further adjusting for plasma triglycerides. CONCLUSION: Our results showed that the -1131T>C polymorphism in APOA5 was associated with the MetS because of its strong effect on plasma triglycerides. This may partly explain the higher cardiovascular risk in people with this polymorphism.
No takes yet. Share an insight, caveat, or question.
Ong et al. (2010) conducted a cohort in Metabolic syndrome (n=3,282). SNP rs662799 (-1131T>C) in the APOA5 gene vs. Subjects without the variant was evaluated on Metabolic syndrome (OR 1.47, p=0.00082). The APOA5 SNP rs662799 (-1131T>C) was significantly associated with metabolic syndrome in Chinese subjects (OR 1.47, P=0.00082), largely driven by its effect on plasma triglycerides.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: